Peter Thiel
Peter Thiel is the President of Clarium Capital Management, a hedge fund with $6 billion under mangement. Peter co-founded PayPal and served as its Chairman and CEO until the company's sale to eBay in October 2002 for $1.5 billion. Peter's experience in finance includes managing a successful hedge fund, trading derivatives at CS Financial Products, and practicing securities law at Sullivan & Cromwell. Peter sits on the Board of Directors of the Pacific Research Institute and on the Board of Visitors of Stanford Law School. Peter received his BA in Philosophy and his JD from Stanford.
View Older Stories View More Recent Stories
-
Recharge Capital Announces $200M Women’s Healthcare Investment Holdings Co. With a Novel Structure
-
Collectibles.com Raises $5M Seed Round to Launch the World's First Web3 Collector Community and Marketplace
-
Palantir (PLTR) Mentioned as Short at Bear Cave
-
Peptilogics Reports Positive 90-Day Top Line Interim Data From Phase 1b Trial of PLG0206 in Patients With Periprosthetic Joint Infection (PJI)
-
BuildOps Raises $50 Million to Revolutionize Commercial Contracting
-
Bitcoin Company River Raises $35 Million In Series B Funding
-
Exclusive-Peter Thiel, Republican megadonor, won’t fund candidates in 2024 - sources
-
Peter Thiel, Republican Megadonor, Won’t Fund Candidates In 2024 - Reuters
-
Inside Meta's scramble to catch up on AI
-
Intelligence Squared U.S. Is Becoming "Open to Debate"
-
Peptilogics Completes Phase 1b Trial Enrollment and Will Present Interim Top-line Safety and Tolerability Data of PLG0206 in Patients Undergoing DAIR for the Treatment of Periprosthetic Joint Infectio
-
Spencer Trask & Co. Venture Fastcase Merges with Legal Intelligence Platform vLex
-
Social media-driven bank runs burden regulators with a bigger problem
-
First Citizens agrees to buy collapsed Silicon Valley Bank
-
Peter Thiel had $50 million at SVB when it collapsed - FT
-
How SVB Financial Group imploded in two days
-
U.S. CPI, bank stocks' dead cat bounce, oil hits 2023 low - what's moving markets
-
Explainer-What caused Silicon Valley Bank's failure?
-
Silicon Valley Bank scrambles to reassure clients after 60% stock wipe-out
-
REGENT Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
-
REGENT Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
-
Rescale Named to Y Combinator's Top Companies List for Fifth Year in a Row
-
Peptilogics Hosting Panel Discussion with Leading Industry Experts on the High Unmet Medical Need and Opportunity in Periprosthetic Joint Infections (PJI)
-
Palantir Q4 results top estimates amid new contract wins; analysts remain cautious
-
Ukraine is using Palantir's software for 'targeting,' CEO says
-
GURUFIN PROJECT: Invited as “Keynote Speakers” at DLD Munich 2023
-
Trade Republic Offers 2 Percent Interest on Cash for All Customers
-
Crypto firm Bullish, Far Peak call off $9 billion SPAC deal
-
Peter Thiel Alum Rebrands Venture Capital Firm as Aloft VC
-
Explainer-ChatGPT: What is OpenAI’s chatbot and what is it used for?
-
Pylon Closes $8.5M Seed Round to Build the Embedded Mortgage Infrastructure Platform
-
Crypto lender BlockFi files for bankruptcy, cites FTX exposure
-
Democrat Mark Kelly holds seat in Arizona's U.S. Senate race
-
Factbox-Georgia U.S. Senate race going to runoff
-
Factbox-Democrat Fetterman wins U.S. Senate seat in Pennsylvania, Edison Research projects
-
Mastodon: What is the social network hailed as a Twitter alternative?
-
This Week in Transportation News: 7 Stories You Need to See
-
HD Hyundai CEO Chung Ki-sun Discussed Business Expansion with Chairman Peter Thiel of Palantir Technologies
-
Factbox-From outer space to social media, Elon Musk's growing universe
-
Techonomy 2022 Launches "Innovation Must Save the World" Conference
-
Peptilogics to Present Data at IDWeek 2022 on PLG0206, an Engineered Antimicrobial Peptide Targeting Bacteria Causing Periprosthetic Joint Infection
-
Mercantile Launches Industry-Specific Credit Card Platform That Supports Small Business Success
-
Peptilogics Presents Data Demonstrating Antimicrobial Activity Against Difficult to Treat Bacterial Pathogens of Engineered Peptide PLG0206 at the 2022 ASM/ESCMID Joint Conference on Drug Development
-
Peptilogics Announces First Patient Dosed in Phase 1b Study of PLG0206 for Periprosthetic Joint Infection
-
Outside dollars help Republican U.S. Senate candidates close financial gap with Democrats
-
Factbox-Eight U.S. Senate races to watch in November's midterm elections
-
Palantir signs $20 million deal with S.Korea's Hyundai Heavy Industries
-
Portofino Technologies Announces $50 Million Investment to Build Financial Infrastructure Technology to Power Digital Asset Adoption
-
QA Wolf Launches with over 20 Million Dollars to Bring Zero-Effort Automated QA to Developers at Scale
-
American voters deluged by ads in fight to control Congress, future elections

